Live from the NIH registry
Studies recruiting near Corpus Christi right now
Top 25 of 67 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Prurigo Nodularis
Phase 3
Interventional 18 participants sought
Driscoll Children's Hospital- Site Number : 8400017 — Corpus Christi, Texas (5.3 mi)
· Sponsor: Sanofi
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Boehringer Ingelheim
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Phase 3
Interventional 3,082 participants sought
South Texas Clinical Research ( Site 3815) — Corpus Christi, Texas (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 38 — Corpus Christi, Texas (5.3 mi)
· Sponsor: BioStem Technologies
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Phase 3
Interventional 1,035 participants sought
Private Practice - Dr. Osvaldo A. Brusco — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Amgen
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
South Texas Clinical Research — Corpus Christi, Texas (5.3 mi)
· Sponsor: Pfizer
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
South Texas Clinical Research — Corpus Christi, Texas (5.3 mi)
· Sponsor: Novo Nordisk A/S
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Single-ventricle
N/A
Interventional 100 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Driscoll Children's Hospital
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Saratoga Surgical Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Stryker Instruments
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
Invasive Fungal Infection
Phase 2
Interventional 40 participants sought
Driscoll Children's Hospital ( Site 2113) — Corpus Christi, Texas (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Chronic Pain, Intractable Pain
N/A
Interventional 70 participants sought
Institute of Precision Pain Medicine — Corpus Christi, Texas (5.3 mi)
· Sponsor: Boston Scientific Corporation
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Obesity, Weight Gain
Phase 3
Interventional 300 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: GlaxoSmithKline